Loading…

BD (Becton, Dickinson and Company) formed a public-private partnership with BARDA to invest $70 million in expanding manufacturing capacity for syringes and needles in Nebraska, with BARDA investing $42 million. BD also finalized an order for 50 million injection devices for COVID-19 vaccination.
“BARDA will invest an estimated $42 million into a $70 million capital project to further expand BD's operations and manufacturing capacity in Nebraska”prnewswire.com
Summarized from public sources; check the original articles before acting on it.